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Trypanosoma cruzi, the causative agent of Chagas' disease which affects a large number
of individuals in Central and South America, is transmitted to vertebrate hosts by
blood-sucking insects. The infective forms of the parasite are the metacyclic
trypomastigotes released with the feces ofthe insect. After invading the mammalian
host, they penetrate cells, multiply as amastigotes, and transform again into
trypomastigotes, which in turn are released into the bloodstream. The majority of
acute human cases ofChagas' disease resolve in a few months but many individuals
develop chronic manifestations of a systemic disease. Paradoxically, these individ-
uals have very few parasites in circulation or in their tissues, but have severe heart
and digestive tract lesions. It is generally assumed that the chronic infection is main-
tained by a few tryposmastigotes in the blood that escape the immune response and
enternew cells, and that amastigotes are exclusively the replicative intracellular stage
of the parasite (1, 2). Here we demonstrate that amastigotes of T. cruzi enter and
multiply in cells in vitro and, when injected intraperitoneally, are as infective to mice
as trypomastigotes.
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Materials and Methods
Parasites.
￿
Strain Y of T . cruziwas maintained in monolayers of LLC-MK2 cells in DME
containing 2olo FCS medium (Gibco Laboratories, Grand Island, NY) at 37'C in a 5% C02
atmosphere (3). To obtain recently released trypomastigotes, LLC-MK2 cells were infected
with parasites and 4 or 5 d later, were washed to remove free parasites, and were reincubated
in fresh medium. Trypomastigotes were collected 4 h later.
In vitro extracellularly developed amastigotes were obtained by incubation of recently
released trypomastigotes in liver infusion tryptose medium (LIT)' (4) for 24, 48, or 72 h
at 37°C in a 5olo C02 atmosphere at a density of 10' parasites/ml. LIT medium was pre-
pared by heating at 68'C for 1 h a solution containing 68 mM NaCl, 5.4 mM KCI, 56 mM
Na2HPO4, 11 MM D-glucose, 3 g/liter of liverinfusion (Difco Laboratories Inc., Detroit, MI)
and 5 g/liter of Bacto Tryptose phosphate broth (Difco Laboratories, Inc.). After cooling,
the pH of the medium was adjusted to 7.2 and 2% hemoglobin from SRBC (Colorado Serum
Co., Denver, CO) was added. The LIT medium was sterilized by filtration and stored at 40C.
The parasites were sedimented by centrifugation (1,000 g for 5 min) and further purification
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was achieved by allowing contaminating motile trypomastigotes to accumulate in the super-
natant during a subsequentincubation at 370C for 2 h. These trypomastigotes were discarded.
The amastigotes developed in LIT medium will be referred to as extracellularly derived
amastigotes, and the number of hours of in vitro cultivation will be given in parentheses.
Entry into Cells and Determination ofMultiplication Rates.
￿
PBMC were isolated from venous
blood of a normal human donor by centrifugation in a Ficoll-Hypaque gradient (Pharmacia
Fine Chemicals, Piscataway, NJ). Monocytes were further purified by the removal of cells
that did not adhere to the bottom of plastic plates (24-well, Falcon Laboratories, Oxnard,
CA). As seen by transmission electron microscopy, the resulting culture consisted overwhelm-
ingly ofmonocytes, with a few contaminating lymphocytes (not shown). The monocytes were
then cultured in RPMI 1640 (Gibco Laboratories) containing 10% fresh human serum, pen-
icillin and streptomycin (Gibco Laboratories). 6 d later the cultures, each containing tit x
105 cells, were exposed to a suspension of 105 parasites (amastigotes or trypomastigotes) per
well. After 4 h of incubation (time zero) the medium was aspirated, and the wells were care-
fully washed with RPMI 1640 to remove free organisms.
3T3 fibroblast cells were irradiated with 4,500 rad and plated onto 24-well plates (1-5 x
105 cells/well). Cells were incubated at 37°C in DME, 10% FCS for 24 h before adding the
parasites. During infections, amastigotes were left in contact with the 3T3 cells for 14 h, then
the cultures were washed and incubated with fresh medium at 37°C in a 5% C02 at-
mosphere from 1 to 6 d.
To permit intracellular development of the parasites, the washed cells were then incubated
for varying periods of time in RPMI 1640, 10°lo fresh human serum at 37°C in a 5% C02
atmosphere. At different time points the cells were scraped off the wells and the whole con-
tents (cells + medium) were centrifuged and processed for parasite DNA determinations.
Pellets were resuspended in a lysis buffer: 10 mM Tris-HCI, pH 7.4, 10 mM EDTA, 150 mM
NaCl, 0.4% SDS, containing 200 wg/ml of proteinase K (Bethesda Research Laboratories,
Bethesda, MD). After incubation for 1 h at 65'C and 3 h at 37 °C, lysates were extracted
with phenol/chloroform and the DNA was blotted onto nitrocellulose discs. A T . cruzi-specific
DNA probe (5) was labeled by the random priming method (1-4 x 109 dpm/kg) (6) and hy-
bridized for 20 h at 42°C in 50% formamide, 5 x SSC (1 x SSC: 0.15 M NaCl, 0.015 M
sodium citrate), 0.5% SDS, and 0.2% cow's milk. Filters were washed twice in 2 x SSC,
0.5% SDS at room temperature, then in 0.5 x SSC, 0.5% SDS at 68°C, and finally in 0.2
x SSC, 0.5% SDS at 68°C. They were then air dried and counted in a scintillation counter.
The amount of T . cruziDNA was calculated from a standard curve made with known amounts
of parasites. Standard curves obtained with equal numbers oftrypomastigotes and amastigotes
were identical.
To determine the proportion of infective parasites in different preparations, the medium
and washes were combined, centrifuged and processed for T . cruziDNA as described above.
Percent infectivity was calculated by measuring the number of parasites associated (A) and
not associated (B) with the cells by the formula: (AIA + B) x 100. In the experiment repre-
sented in Fig. 3, 95% of extracellularly derived (24 h) amastigotes, 35% of intracellularly
derived amastigotes, and 35% of trypomastigotes became associated with the monocytes.
Intracellularly Derived Amastigotes.
￿
Monocyte monolayers were first infected with extracel-
lularly derived (24 h) amastigotes. After45 h, the cells contained only replicating amastigotes
bearing Ssp-4, a major stage-specific glycoprotein (3, 7). The cultured monocytes were scraped
off the plastic culture plates and mechanically disrupted by passing them through a 25-gauge
needle. The parasites were separated from the debris by low-speed centrifugation.
Scanning Electron Microscopy.
￿
Drops of 10 kl (10' parasites/ml in PBS) were placed on 12-
mm round glass coverslips precoated with 10 ug/ml poly-L-lysine (Miles-Yeda, Rehouet Is-
rael). After 15 min at VC, the supernatant was aspirated and parasites were fixed with cold
2% glutaraldehyde, 0.1 M sucrose in 0.1 M sodium cacodylate buffer, pH 7.2 . The coverslips
were kept at 4'C in fixative until processed for scanning electron microscopy, at which time
they were rinsed in buffer and processed as described (3).
Transmission Electron Microscopy.
￿
The parasites of the infected cells were pelleted and fixed
for 2 h at 4°C with 2% glutaraldehyde in 0.1 M sodium cacodylate buffer containing 0.1
M sucrose. After three 0.1 M cacodylate buffer rinses the pellets were osmicated in 2% OS04LEY ET AL.
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in the same buffer, dehydrated in ethyl alcohol, and embedded in Epon 812. Thin sections
were picked up on formvar-coated, carbon-stabilized grids, stained with 1% aqueous uranyl
acetate and 2 % lead citrate, and examined in a Philips 300 transmission electron microscope.
Escapefrom Endocytic Vacuoles.
￿
Human monocytes were cultured as described for 6 d. The
cells were exposed for 1 h to a suspension of extracellularly derived (24 h) amastigotes at
ratios of 50 parasites per cell at 37°C in a 5% C02 atmosphere. Cultures were washed with
RPMI to remove free organisms and reincubated for 1 h, 3 h, or 16 h. Then the infected
cells were fixed with 2% glutaraldehyde, 0.1 M sucrose in 0.1 M sodium cacodylate buffer,
scraped off the plastic, and processed for transmission electron microscopy as described.
Infection ofMice with T . cruzi Parasites.
￿
Groups of four BALB/e female mice (8-12 wk old)
were injected intraperitoneally with 104 , 103 , or 102 extracellularly derived (24 h) amastigotes
or with the same number of trypomastigotes. Mice were bled from the tail every day after
infection and motile trypomastigotes were counted under the microscope.
Results
In the initial experiments we compared the infectivity in vitro for cultured human
monocytes of tissue culture-derived Y strain trypomastigotes and of extracellularly
derived amastigotes. In the preparations ofpurified trypomastigotes and amastigotes
used, the cross-contamination was <1%, as determined by scanning electron mi-
croscopy (Fig. 1). The extracellularly derived resembled the intracellularly derived
amastigotes by scanning (Fig. 1, reference 3) and transmission electron microscopy
(Fig. 2).
To measure the infectivity and the multiplication rates ofthe parasites inside cells,
we used a DNA probe specific for T. cruzi (5). In several experiments, 85 to 95%
of extracellularly derived (24 h) amastigotes, but only 10 to 35,70 oftrypornastigotes,
remained associated with the monocytes after four hours ofincubation (Fig. 3). Iden-
tical results were obtained whether the culture medium contained fresh or heat-
inactivated (56°C, 1 h) human serum, suggesting that complement factors are not
involved. Following invasion, both amastigotes and trypomastigotes replicated as
amastigotes with doubling times of about 10 hours. Trypomastigotes showed a
prolonged lag between invasion and the start of DNA duplication, in contrast to
amastigotes which commenced replication immediately (Fig. 3). Trypomastigotes
exiting from infected cells were detected in all culture media after 4 to 5 d.
The very high infectivity of the extracellularly derived (24 h) amastigotes was fur-
ther demonstrated by limiting dilution experiments. Monocyte monolayers were pre-
pared in flat-bottomed 96-well plates (Falcon Labware). The amastigotes were sus-
pended in RPMI 1640 medium at a concentration of 10 parasites/ml, and 200 Itl
was delivered to each well. The cultures were incubated for 5 d at 37°C and the
wells were examined under the microscope for the presence of free trypomastigotes.
These were found in 8517o ofthe wells. This is very close to the expected result (86.5 %),
calculated from the Poisson distribution and assuming 100% infectivity. Taken to-
gether, these experiments eliminate the possibility that contamination of amastigotes
with trypomastigotes accounted for the infection.
The ability of amastigotes to attach to monocytes in vitro did not diminish when
they were kept in culture for an additional 48 h. 90% of such extracellularly derived
(72 h) amastigotes became associated with the monocytes after 4 h of incubation,
as determined with the DNA probe. Afterinfection, the replication timesof the "older"
and "younger" amastigotes within the monocyte cytoplasm were the same, that is,
10 h (not shown). However, the number of parasites in the monocyte cultures at the652
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FIGURE 1 . Scanning electron micrographs of T . cruzi parasites used for infections : (A)
trypomastigotes, (B) extracellularly derived (24 h) amastigotes. Bars, 10 gm .
end of 5 d was only 50% of that observed after infection of the cells with identical
quantities of extracellularly derived(24 h) amastigotes . It is possible that halfof the
attached "older" parasites did not enter the monocytes or, more likely, that half of
theseparasites did not survive intracellularly . Onedifference between "younger"and
"older" extracellularly derived parasites is the smaller amounts of the stage-specific
glycoprotein Ssp-4 (7) in the latter, but whether this is the cause of the diminished
infectivity is unknown.LEY ET AL .
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FIGURE 3 .
￿
Infectivity and kinetics ofmultiplication ofT . cruzi para-
sites in human monocytes. Values represent the mean amount of
parasiteDNA in four wells, and bars the standard deviations. Time
zero is the time when the free parasites were removed, that is, after
4 h of incubation with the monocytes .
Because it couldbe argued that intracellularlyand extracellularly derivedamastigotes
are different, we repeated the same experiments with a preparationof intracellularly
derived amastigotes . These were suspended in medium and incubated with human
monocyte monolayers for4 h. 30% ofthem entered the cells and started to replicate
without a lag (Fig . 3), with a doubling time of 10 h. After 4-5 d trypomastigotes
were found in the culture medium.
FIGURE 4 .
￿
Human monocytes infected with extracellularly derived (24 h) amastigotes 1 h after
the entry of the parasites, as seen by transmission electron microscopy . Some amastigotes are
in phagocytic vacuoles andsome are free in the cytoplasm (arrows) . Lysosomescanbe seen fused
with the membrane of vacuoles containing parasites . Bar, 1 gym .6
5
4
3
2
1
6
5
4
3
2
1
r
irk . Amast
Pome~s i03
In1M,p
er
102
5 6 7 8 9 10 11 12 13 14 15 16
Time After Infection (Days)
LEY ET AL.
￿
65 5
FIGURE 5.
￿
Parasitemia in infected mice. Groups offour mice
were injected intraperitoneally with 104, 103, or 102 amasti-
gotes(top panel) or trypomastigotes (bottom pano. Parasitemia
represents the mean number of motile trypomastigotes per
microliter ofbloodin four animals, andbars thestandard devi-
ations. All mice died between 18 and 25 d after infection.
Amastigotes also infected nonprofessional phagocytic cells in vitro, albeit with a
much lower efficiency. After 14 h of incubation, 2070 of extracellularly derived (24
h) amastigotes entered 3T3 fibroblasts and these parasites replicated with a dou-
bling time of -12 h (not shown).
The ability of theamastigotesto rapidlyescape thephagocytic vacuoles was demon-
stratedby transmission electron microscopy. After 2 h ofincubation with monocytes
(1 h in the presence of parasites and one additional hour after the removal of those
parasites free in the medium) a few extracellularly derived (24 h) amastigotes were
seen free in the cytoplasm (Fig. 4) while most remained within the vacuoles. The
number of free amastigotes increased with the time of incubation, and after 16 h,
almost all of them were out of the vacuoles (not shown). Lysosomes fusing with the
membranes of vacuoles containing parasites were frequently observed. In many in-
stancesthevacuoles contained an opaque material, most likely representing lysosomal
products (Fig. 4).
To study the in vivo infectivity of the extracellularly derived (24 h) amastigotes,
we inoculated groups of five A/J mice intraperitoneally with either 102, 103, or 104
ofthem. Controlanimalswere inoculated with the same number of tissue culture-de-
rived trypomastigotes recently released from LLC-MK2 cells. All mice were infected
and died 18-25 d afterwards, following two peaks of trypomastigote parasitemia on
days 7 and 12 (Fig. 5). Significantlyhigher numbers of parasiteswere observed during
the second peak of parasitemia in mice inoculated with amastigotes.
Discussion
We showed here that both extracellularly derived (24 h) amastigotes and intracel-
lularly derived amastigotes of T . cruzi entered human monocytes in vitro, divided
with identical replication times (10 h), and developed into trypomastigotes. The ex-
tracellularly derivedamastigotes were identicalto theintracellularlyderivedamastigotes
by several different criteria, that is, the morphology of the bar in their kinetoplasts
as shown by transmission electron microscopy (Figs. 2 and 4), their morphology
by scanning electron microscopy (Fig. 1), and thepresence of an amastigote-specific
surface glycoprotein (Ssp-4)on their cell membranes(7). Ssp-4expression is maximal656
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in "young" amastigotes and is progressively shed during their development either
intra- or extracellularly (7).
Greater than 90% of the extracellularly derived, but only 30% of the intracellu-
larly derived amastigotes were infective for monocytes. Possible reasons forthe lower
infectivity of the intracellularly derived amastigotes are that they were isolated from
cells by a relatively harsh procedure, and were contaminated by cellular materials,
which could have affected the viability of the parasites.
Extracellularlyderived(24h) amastigotes also entered anddeveloped within fibro-
blasts, cells which are not professional phagocytes. Although their infectivity was
in this instance much lower, once they entered the cells the kinetics of intracellular
multiplication and transformation into trypomastigotes was similar to that observed
during their development in human cultured monocytes.
The development patterns of extracellularly derived or intracellularly derived
amastigotes within monocytes were similar. Their replication times were identical
(10 h), and there was no apparent lag period before the start of DNA replication,
contrasting with the ti20-h lag seen when trypomastigotes invaded the same cells
(Fig. 3). This lag was also reported by Dvorak and collaborators (8, 9) and, at least
in part, it must represent the time necessary forthe transformation oftrypomastigotes
into amastigotes. However, the cellular site where this transformation takes place
is unknown. T, cruzi develops in the cytoplasm of host cells (10-12) and the parasite
must destroy the membrane of the phagocytic vacuole to escape. As shown here,
extracellularly derived (24 h) amastigotes have this ability, since they are found in
the cytoplasm a few hours after entering cells. Perhaps the induction of the mem-
branolytic agents, such as, for example, phospholipases, is stage specific and
trypomastigotes first have to transform into amastigotes inside the vacuole before
they can escape and start to replicate.
Thedevelopmental potential of amastigotes hasbeen amatter ofcontroversy. Vil-
lalta and Kierszenbaum (13) reported that amastigotes from continuous acellular
cultures (in contrast to our recently transformed amastigotes) were destroyed in the
phagocytic vacuoles of cultured human monocytes. Carvalho et al. (14) and Gut-
teridge et al. (15) showed that amastigotes isolated from the spleen or muscle of mice
were not infective to mouse peritoneal macrophages or infective when injected into
animals. Umezawa et al. (16) reported that amastigotes entered mousemacrophages
in vitro but did notdifferentiate into trypomastigotes. There are twopossible expla-
nations forthesenegative results. The survival of amastigotes in macrophagesprob-
ably depends on the degree of activation of the phagocytes (17, 18), and/or the
amastigotes used by these investigators might not have been viable intracellularly
because they had developedtoolong in vitroor in vivo. As shown here, only "young"
amastigotes are fully infective.
Other studies using amastigotes purified from different sources showed that they
entered and developed in cells in vitro and in infected mice (11, 19-25). However,
parasite developmentin vitro was estimatedonly by light microscopy, and the propor-
tion of infective parasites in the population or their rates of multiplication were not
evaluated.
Our findings settle the controversy as to whether or not amastigotes themselves
can infect mammalian cells, since they showed directly by two independent ex-
perimental approaches that 90% or more ofextracellularly derived(24 h) amastigotesLEY ET AL.
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infected monocytes. Furthermore, these amastigotes were as infective to mice as
trypomastigotes were; the prepatent periods and the number of trypomastigotes in
the blood during the first peak of parasitemiawere quitesimilar. In fact, the number
of trypomastigotes in the blood during the second peak ofparasitemia was significantly
higher in mice inoculated with amastigotes. This difference can be explained if, in
theanimals infected with trypomastigotes, theimmune response to trypomastigote-
specific antigens (3, 26, 27) developedearlierthan in mice infected with amastigotes.
This is likely because the immune system of the latter animals came in contact with
trypomastigotes only after the first intracellular replication cycle. These emerging
trypomastigotes would then be less likely to be destroyed by immune mechanisms
and the parasitemias would reach higher levels than in mice initially infected with
trypomastigotes.
On the basis ofthese observations, thepossibility of an alternative developmental
cycle for T . cruzi within the mammalian host with the participation of infective
amastigotes, should be entertained. In vivo, the infective amastigotes could emerge
from cells containing either amastigotes or mixtures oftrypomastigotes and amastigotes
or, alternatively, originate from the extracellular transformation of trypomastigotes
into amastigotes. Blood stage trypomastigotes can transforminto amastigotes whether
or not they enter cells (3) and, during the acute stage of the infection, amastigotes
and intermediate forms have been found in largenumbers in the circulation ofmice
(3) and also in the extracellular space between heart muscle cells (23). Extracellular
amastigotes may also be present during the chronic stage of Chagas' disease. How-
ever, at this stage parasites in the blood arevery scarce andthe nonmotile amastigotes
would be virtually impossible to detect by light microscopy. Amastigotes are also
found in the intermediate host, but little is know about their developmental poten-
tial (2).
The present observations areof relevance to the biology, immunoprophylaxis, and
pathology of T . cruziinfections in humans. Since host cells can be invaded by both
trypomastigotes and amastigotes, which bear distinct surface antigens, different stages
of T . cruzimost likely are able to usedifferentmechanisms for attachment andpenetra-
tion into cells. This represents an important survival advantage and could in part
explain the remarkably wide range of definitive hosts of this parasite, which infects
over 100 mammalian species from several orders, and develops in vivo in macro-
phages, as well as in muscle, epithelial, and nervous tissue cells (1, 2). The realiza-
tion that different T . cruzi stages may use different strategies for entering cells of
the vertebrate host complicates the development of vaccines, and also raises ques-
tions regarding the relative importance of the two infective stages in perpetuating
the infection leading to the chronic phase of Chagas' disease.
Summary
The two main stages of development of the protozoan parasite Trypanosoma cruzi
found in the vertebrate host are the trypomastigote and the amastigote. It has been
generally assumed that only trypomastigotes are capable of entering cells and that
amastigotes are the intracellular replicative form of the parasite. We show here that
after incubation for 4 h with human monocytes in vitro 90% or more of extracellu-
larly derived (24 h) amastigotes of T . cruzi are taken up by the cells. Within 2 h
they escape the phagocytic vacuole and enterthe cytoplasm, where they divide and658
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after 4-5 d transform into trypomastigotes. Trypomastigotes also invade cultured
human monocytes. However, they show a lag of several hours between invasion and
the start of DNA duplication, while amastigotes commence replication without an
apparent lag. Amastigotes also infect cultured fibroblasts, albeit with lower efficiency.
When injected intraperitoneally into mice, amastigotes are as infective as trypomasti-
gotes. Based on these results, and on prior findings that amastigotes are found free
in the circulation of mice during the acute stage of the disease (3), it seems likely
that the cellular uptake of amastigotes can initiate an alternative subcycle within
the life cycle of this parasite in the mammalian host. Also, because trypomastigotes
and amastigotes have diverse surface antigens, they may use different strategies to
invade host cells.
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of the manuscript.
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